Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02723656 · ClinicalTrials.gov registry record · NA
Proactive Care Coordination for Cancer Survivors Who Smoke
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 581
- Enrollment target
NCT02723656 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 581 participants.
The verdict
NCT02723656, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 581 participants
- Enrollment target
Study Summary
This is a population-based randomized controlled trial of 600 patients with a diagnosis of cancer in the past 2 years and registry indicating smoking at the time of diagnosis, that will inform critical questions regarding the relative efficacy of care coordination options, the reliability of Electronic Health Record (EHR) tobacco use data, and how patients will react to proactive tobacco related communications. Investigators will compare the reach and efficacy of two proactive approaches to enrolling cancer survivors in tobacco treatment (Arm 1: mailed care coordination vs. Arm 2: telephone care coordination) using a two-arm randomized design at two urban cancer centers, and will explore cancer survivor attitudes and preferences about proactive tobacco treatment.
Interventions
- BEHAVIORAL Online Referral NYS Quitline
- BEHAVIORAL Tobacco cessation counseling and coordination of cessation medications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 581 participants |
| Start Date | 2016-03 |
| Est. Completion | 2018-09-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02723656
The ClinicalTrials.gov registry entry for NCT02723656 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 581 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Online Referral NYS Quitline is the first listed.
NCT02723656 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02723656 about?
NCT02723656 is a clinical study titled "Proactive Care Coordination for Cancer Survivors Who Smoke". This is a population-based randomized controlled trial of 600 patients with a diagnosis of cancer in the past 2 years and registry indicating smoking at the time of diagnosis, that will inform critical questions regarding the relative efficacy of care coordination options, the reliability of Electro...
What is the current status of trial NCT02723656?
This trial is currently completed. It is a NA study. The enrollment target is 581 participants. The study started on 2016-03. Estimated completion is 2018-09-29.
What interventions are being tested in trial NCT02723656?
The interventions under investigation include: Online Referral NYS Quitline (BEHAVIORAL), Tobacco cessation counseling and coordination of cessation medications (BEHAVIORAL).
Who is sponsoring clinical trial NCT02723656?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.